Table 2.
Number of patients (%) | Age in years (range) | |
---|---|---|
Sex | ||
Male | 9 (60%) | |
Female | 6 (40%) | |
Age at time of focus group | ||
Median (range) years | 46 (25–75) | |
Age at time of diagnosis | ||
Median (range) years | 43 (16–75) | |
Marital status | ||
Single | 3 (20%) | |
Married | 9 (60%) | |
Partnership | 2 (13%) | |
Windowed | 0 (0%) | |
Divorced | 1 (7%) | |
Nationality | ||
Dutch | 14 (93%) | |
Other | 1 (7%) | |
Highest completed education | ||
Elementary education | 1 (7%) | |
Secondary education | 2 (13%) | |
Middle-level applied education | 3 (20%) | |
Higher professional education | 6 (40%) | |
Scientific education (university) | 1 (7%) | |
Missing value | 2 (13%) | |
Current paid employment | ||
Yes | 8 (53%) | |
No | 5 (33%) | |
Retired | 2 (13%) | |
Familiar with DTF before diagnosis | ||
Yes | 0 (0%) | |
No | 15 (100%) | |
Location of DTF | ||
Head/neck | 1 (7%) | |
Upper extremity/shoulder | 2 (13%) | |
Thoracic wall | 0 (0%) | |
Abdominal wall | 4 (27%) | |
Back | 1 (7%) | |
Retroperitoneal/intra-abdominal | 2 (13%) | |
Hip/pelvis/gluteal region | 2 (13%) | |
Lower extremity | 3 (20%) | |
Received treatment(s) | ||
Conservative management | 4 (27%) | |
Surgery | 8 (53%) | |
Radiation therapy | 0 (0%) | |
Systemic therapy | 0 (0%) | |
Combination of therapiesa | 3 (20%) | |
Contact with healthcare professionals | ||
Physiotherapist/occupational therapist | 5 | |
Dietician | 1 | |
Social worker | 2 | |
Psychologist | 1 | |
Pain specialist | 1 | |
Home care/nursing care | 1 | |
Otherb | 1 | |
Self-reported symptomsc | ||
Lump with obvious growth | 10 | |
Pain | 3 | |
Tumour complains during daily activities | 8 | |
Functional limitations (before treatment) | 3 | |
Self-reported medical historyc | ||
Surgery related desmoid | 6 | |
Desmoid related to hormonal status | 3 |
a n = 1 surgical resection with post-operative radiotherapy, n = 1 surgical resection, radiotherapy, and isolated limb perfusion (ILP), n = 1 surgical resection (with final amputation of the lower leg, radiotherapy, ILP, hormonal therapy, experimental chemotherapy)
bLymphatic therapy
cObtained during the focus group sessions as reported by the patients